Clinical breakthrough in foot and ankle surgery which will be presented at AOFAS
Improving patients’ lives through collaborative support of orthopaedic and musculoskeletal research.
Clinical Breakthrough in Foot & Ankle Surgery!
The Orthopedic Foot and Ankle Center (OFAC) just completed a prospective, IRB-approved clinical study showing excellent outcomes using CartiMax for osteochondral defects of the talus—a notoriously difficult area to treat.
- 100% success rate
- No intraoperative complications or graft failures
- Significant improvements in pain (VAS) and function (AOFAS)
- Full radiographic integration of the scaffold in all patients
- No revisions needed during follow-up
Led by Dr. Steven Neufeld, the study will be presented at the upcoming AOFAS Annual Meeting. CartiMax—a next-gen cartilage repair scaffold—is showing strong promise in regenerating both cartilage and subchondral bone in complex joint areas like the talus.
A larger cohort study is already in the works as OFAC continues to advance biologic repair solutions in orthopedic care.
#Orthopedics #FootAndAnkle #CartilageRepair #Biologics #CartiMax #AOFAS #TalusRepair #InnovationInMedicine
The CAO Research Foundation previews an exciting clinical breakthrough to be showcased at AOFAS — spotlighting the innovation driving the future of foot and ankle surgery. At Surgzon, we track and support advancements that shape better surgical outcomes.
Catch more highlights before and after the congress at surgzon.com | Follow us for the latest in foot & ankle excellence.
#AOFAS2025 #FootAndAnkleSurgery #ClinicalBreakthrough #OrthopaedicInnovation #ConferenceHighlights #Surgzon #FollowSurgzon
